Free Trial
NASDAQ:NAGE

Niagen Bioscience (NAGE) Stock Price, News & Analysis

Niagen Bioscience logo
$9.98 +0.21 (+2.15%)
As of 04:00 PM Eastern

About Niagen Bioscience Stock (NASDAQ:NAGE)

Key Stats

Today's Range
$9.72
$10.14
50-Day Range
$9.04
$14.41
52-Week Range
$3.10
$14.69
Volume
863,917 shs
Average Volume
1.19 million shs
Market Capitalization
$795.91 million
P/E Ratio
47.53
Dividend Yield
N/A
Price Target
$13.42
Consensus Rating
Buy

Company Overview

Niagen Bioscience Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
27th Percentile Overall Score

NAGE MarketRank™: 

Niagen Bioscience scored higher than 27% of companies evaluated by MarketBeat, and ranked 835th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Niagen Bioscience has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Niagen Bioscience has only been the subject of 3 research reports in the past 90 days.

  • Read more about Niagen Bioscience's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Niagen Bioscience is 47.53, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 28.40.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Niagen Bioscience is 47.53, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 31.10.

  • Price to Book Value per Share Ratio

    Niagen Bioscience has a P/B Ratio of 12.48. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for NAGE.
  • Dividend Yield

    Niagen Bioscience does not currently pay a dividend.

  • Dividend Growth

    Niagen Bioscience does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for NAGE.
  • News Sentiment

    Niagen Bioscience has a news sentiment score of 0.11. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.64 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 7 news articles for Niagen Bioscience this week, compared to 3 articles on an average week.
  • Search Interest

    Only 4 people have searched for NAGE on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.
  • MarketBeat Follows

    Only 3 people have added Niagen Bioscience to their MarketBeat watchlist in the last 30 days. This is a decrease of -82% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Niagen Bioscience insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 9.39% of the stock of Niagen Bioscience is held by insiders.

  • Percentage Held by Institutions

    Only 15.41% of the stock of Niagen Bioscience is held by institutions.

  • Read more about Niagen Bioscience's insider trading history.
Receive NAGE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Niagen Bioscience and its competitors with MarketBeat's FREE daily newsletter.

NAGE Stock News Headlines

Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.tc pixel
Unlocking Cellular Health With Science and Trust
HC Wainwright Has Negative Outlook for NAGE Q3 Earnings
Niagen Bioscience (NASDAQ:NAGE) Price Target Raised to $12.00
See More Headlines

NAGE Stock Analysis - Frequently Asked Questions

Niagen Bioscience's stock was trading at $5.48 on January 1st, 2025. Since then, NAGE stock has increased by 82.1% and is now trading at $9.98.

Niagen Bioscience, Inc. (NASDAQ:NAGE) announced its earnings results on Wednesday, August, 6th. The company reported $0.04 EPS for the quarter, topping the consensus estimate of $0.02 by $0.02. The firm earned $31.12 million during the quarter, compared to analysts' expectations of $28.55 million. Niagen Bioscience had a net margin of 15.24% and a trailing twelve-month return on equity of 23.12%.

Shares of NAGE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
8/06/2025
Today
8/22/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:NAGE
Previous Symbol
NASDAQ:NAGE
CIK
1386570
Web
N/A
Employees
120
Year Founded
N/A

Price Target and Rating

High Price Target
$23.00
Low Price Target
$8.00
Potential Upside/Downside
+34.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
5 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.21
Trailing P/E Ratio
47.53
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$8.55 million
Net Margins
15.24%
Pretax Margin
15.76%
Return on Equity
23.12%
Return on Assets
15.53%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.88
Quick Ratio
3.24

Sales & Book Value

Annual Sales
$116.30 million
Price / Sales
6.84
Cash Flow
$0.06 per share
Price / Cash Flow
162.81
Book Value
$0.80 per share
Price / Book
12.48

Miscellaneous

Outstanding Shares
79,753,000
Free Float
72,264,000
Market Cap
$795.93 million
Optionable
N/A
Beta
2.12
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (NASDAQ:NAGE) was last updated on 8/22/2025 by MarketBeat.com Staff
From Our Partners